Advertisement
U.S. Markets closed

Artelo Biosciences, Inc. (ARTL)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
1.2400+0.0600 (+5.08%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.71M
Enterprise Value -1.77M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.51
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.21

Trading Information

Stock Price History

Beta (5Y Monthly) 1.36
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.7500
52 Week Low 31.0000
50-Day Moving Average 31.1944
200-Day Moving Average 31.3606

Share Statistics

Avg Vol (3 month) 39.77k
Avg Vol (10 day) 319.79k
Shares Outstanding 53.23M
Implied Shares Outstanding 6N/A
Float 83.2M
% Held by Insiders 10.83%
% Held by Institutions 10.80%
Shares Short (Sep 30, 2024) 433.26k
Short Ratio (Sep 30, 2024) 44.77
Short % of Float (Sep 30, 2024) 41.04%
Short % of Shares Outstanding (Sep 30, 2024) 41.03%
Shares Short (prior month Aug 30, 2024) 445.81k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 21, 2019
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.33%
Return on Equity (ttm)-88.58%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-10.44M
Diluted EPS (ttm)-3.3500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.6M
Total Cash Per Share (mrq)1.74
Total Debt (mrq)120k
Total Debt/Equity (mrq)1.64
Current Ratio (mrq)6.56
Book Value Per Share (mrq)2.26

Cash Flow Statement

Operating Cash Flow (ttm)-9.4M
Levered Free Cash Flow (ttm)-5.61M